Back To Search Instructions
Protocols
23 protocols meet the specified criteria
Disease Site: Breast - Female
Protocol No.TitleStatus
0600000477DATABASE FOR INDIVIDUALS AT HIGH RISK FOR BREAST, OVARIAN AND OTHER HEREDITARY CANCERSOpen
0800000599Use of Remnant Skin from Mastectomy for Development of Skin Cancer BiomarkersOpen
1000000366Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast CancerOpen
1000000478 I-SPY 2 TRIAL : (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2) Open
1200000080NSAID Effects on Clinical and Imaging Breast BiomarkersOpen
1200000123Cognitively-Based Compassion Training (CBCT) for Breast Cancer SurvivorsOpen
1200000138Biospecimen Repository for Individuals at High Risk for Breast, Ovarian, or Other Hereditary CancersOpen
1300000027S1207, "Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer."Open
1300000153Investigating DNA repair mechanisms, hypoxia and hypoxia signaling pathway markers in breast cancer patientsOpen
1300000477A Single-arm Phase II Trial to Evaluate Serum Estradiol Levels in Patients with Breast Cancer Treated with Vaginal Estrogen, EstringOpen
1300000483Chronic Oral Bicarbonate Feasibility StudyOpen
1300000596Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk Open
1300000612A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493, a pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, in Subjects With Advanced or Refractory Solid Tumors or Lymphoma Open
1300000688Concurrent Xeloda and RT for Breast CancerOpen
1300000710A single arm Phase II trial to assess association of BRCA1 protein expression with overall response rate in patients with metastatic breast cancer on pegylated liposomal doxorubicinOpen
1312169608Phase II Trial of Metronomic Eribulin (Halaven) In Pretreated Metastatic Breast Cancer (MBCOpen
1402224036A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer Open
1403248464Alliance A011106 ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III StudyOpen
1405319753The Pharmacogenomics of estrogen receptor (ER) positive breast cancerOpen
1406349968An early phase clinical trial to evaluate the feasibility of CEST MRI in patients with early stage breast cancer Open
1406366673S1222 Fulvestrant Alone Versus Fulvestrant and Everolimus Versus Fulvestrant, Everolimus and Anastrozole: A Phase III Randomized Placebo-Controlled Trial In Postmenopausal Patients With Hormone-Receptor Positive Stage IV Breast Cancer.Open
1408438520A011202 A RANDOMIZED PHASE III TRIAL EVALUATING THE ROLE OF AXILLARY LYMPH NODE DISSECTION IN BREAST CANCER PATIENTS (CT1-3 N1) WHO HAVE POSITIVE SENTINEL LYMPH NODE DISEASE AFTER NEOADJUVANT CHEMOTHERAPYOpen
1409467985A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant ChemotherapyOpen